ERBB2 and breast carcinoma: In HER2 tumorigenic mouse model of breast cancer, it was observed that selective inhibition of NF-κB substantially regulated the initiation & proliferation of cancerous cells, inflammation, recruitment of TAMs and colony formation in mammary gland.